Ultrasound-mediated drug/gene delivery in solid tumor treatment

Journal of Healthcare Engineering

Volumn 4, Issue 2, 2013, Pages 223-254

  Zhou, Yufeng ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Bubble cavitation; Drug vehicle; Drug gene delivery; Sonoporation; Ultrasound

Indexed keywords

ACOUSTIC FIELDS; CAVITATION; CHEMOTHERAPY; DRUG DELIVERY; LIPOSOMES;

BUBBLE CAVITATION; DRUG VEHICLES; DRUG/GENE DELIVERY; IMAGING GUIDANCE; INTERSTITIAL SPACE; REDUCED TOXICITY; SITE-SPECIFICITY; SONOPORATION;

ULTRASONICS;

ADENOVIRUS VECTOR; ALBUNEX; CARMUSTINE; CELL SURFACE RECEPTOR; DOXORUBICIN; DRUG CARRIER; DRUG VEHICLE; ECHO CONTRAST MEDIUM; FLUOROCARBON; FLUOROURACIL; HEMATOPORPHYRIN DERIVATIVE; LIPOSOME; MACROGOL; NANOPARTICLE; PACLITAXEL; PERFLUOROPENTANE; PERFLUTREN; PHOTOFRIN II; PLASMID DNA; POLYSTYRENE; SHU 508; SULFUR HEXAFLUORIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; DNA;

ACOUSTIC IMPEDANCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENO ASSOCIATED VIRUS; ALZHEIMER DISEASE; ANGIOGENESIS; ARTICLE; ATMOSPHERIC PRESSURE; BLOOD VESSEL WALL; BODY TEMPERATURE; BREAST CANCER; CANCER THERAPY; CARDIOTOXICITY; CELL MEMBRANE; CRITICAL MICELLE CONCENTRATION; DEMENTIA; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DRUG RESISTANCE; DRUG TARGETING; ECHOGRAPHY; ENCAPSULATION; EXTRACELLULAR MATRIX; GAS DIFFUSION; GENE DELIVERY SYSTEM; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GLASS TRANSITION TEMPERATURE; GLIOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIPID MONOLAYER; LIPOSOMAL DELIVERY; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG CAPILLARY; METASTASIS; MICELLE; MICROBUBBLE; MICROCIRCULATION; MICROTUBULE ORGANIZING CENTER; MICROWAVE THERAPY; MOOD DISORDER; NANOEMULSION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSCILLATION; OVARY CANCER; PANCREAS CANCER; PARKINSON DISEASE; PHASE TRANSITION; POLYMERIZATION; RETICULOENDOTHELIAL SYSTEM; SHEAR STRESS; SHOCK WAVE; SOLID TUMOR; SOUND INTENSITY; STATIC ELECTRICITY; THROMBOCYTE ACTIVATION; TIGHT JUNCTION; TISSUE PRESSURE; TUMOR GROWTH; TUMOR VASCULARIZATION; ULTRASOUND; ULTRASOUND THERAPY; VAPORIZATION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ELECTROCHEMOTHERAPY; GENE THERAPY; GENETICS; METHODOLOGY; NEOPLASM; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA; ELECTROCHEMOTHERAPY; GENETIC THERAPY; HUMANS; NEOPLASMS; SONICATION;

MLCS; MLOWN;

EID: 84881246125     PISSN: 20402295     EISSN: 20402309     Source Type: Journal    
DOI: 10.1260/2040-2295.4.2.223     Document Type: Article

References (106)

1. Howlader N, Noone AM, Krapchom M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, DLewis DR, Chen HS, Feuer EJ, Cronin KA and Edwards BK. SEER cancer statistics review. National Cancer Institute, 2011, 1975-2008.
2. Curti BD. Physical barriers to drug delivery in tumors, in: B.A. Chabner (ed). Cancer Chemotherapy and Biotherapy, 1996, 709-719.
3. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 2005, 307: 58-62.
4. Boucher Y, Baxter LT and Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res., 1990, 50: 4478-4484.
5. McKee TD, Grandi P, Mok W, Alexandrakis G, Insin N, Zimmer JP, Bawendi M, Boucher Y, Breakefield XO and Jain RK. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res., 2006, 6: 2509-2513.
6. Awada A and Piccart M. Strategies offering protection from the toxic effects of anticancer treatments with a focus on chemoprotective agents. Curr. Opin. Oncol., 2000, 12: 289-296.
7. Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC and Perry MC. Cardiotoxicity of cancer therapy. J. Clin. Oncol., 2005, 23: 7685-7696.
8. Briggers I, Dubernet C and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews, 2012, 54: 631-651.
9. Hernot S and Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Advanced Drug Delivery Reviews, 2008, 60: 1153-1166.
10. Kremkau FW, Kaufmann JS, Walke MM, Burch PG and Spurr CL. Ultrasonic enhancement of nitrogen mustard cytotoxicity in mouse leukemia. Cancer, 1976, 37: 1643-1647.
11. ter Haar G. Ultrasound mediated drug delivery: A 21st century phoenix? International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2012, 28(4): 279.
12. Postema M and Gilja OH. Ultrasound-directed drug delivery. Current pharmaceutical biotechnology, 2007, 8(6): 355-361.
13. Tachibana K and Tachibana S. The use of ultrasound for drug delivery. Echocardiography, 2003, 18(4): 323-328.
14. Shortencarier MJ, Dayton PA, Bloch SH, Schumann PA, Matsunaga TO and Ferrara KW. A method for radiation-force localized drug delivery using gas-filled liposomes. IEEE transactions on Ultrasonics, Ferroelectrics and Frequency Control, 2004, 51: 822-831.
15. Cosgrove D. Ultrasound contrast agents: an overview. European Journal of Radiology, 2006, 60(3): 324-330.
16. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR and Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multicenter experience. Journal of the American College of Cardiology, 2009, 53(1): 32-38.
17. Ferrara K, Pollard R and Borden M. Ultrasound microbubble contrast agents: fundamentals and applications to gene and drug delivery. Annual Review of Biomedical Engineering, 2007, 9: 415-447.
18. Klibanov AL. Microbubble contrast agents: targeted ultraound imaging and ultrasound-assisted drugdelivery applications. Investigative Radiology, 2006, 41(3): 354-362.
19. Unger EC, Matsunaga TO, McCreery T, Schumann P, Sweitzer R and Quigley R. Therapeutic applications of microbubbles. European Journal of Radiology, 2002, 42: 160-168.
20. Unger EC, Hersh E, Vannan M, Matsunaga TO and McCreery T. Local drug and gene delivery through microbubbles. Progress in Cardiovascular Diseases, 2001, 44(1): 45-54.
21. Unger EC, McCreery TP, Sweitzer RH, Caldwell VE and Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Investigative Radiology, 1998, 33(12): 886.
22. Lentacker I, De Smedt SC and Sanders NN. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter, 2009, 5: 2161-2170.
23. Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Advanced Drug Delivery Reviews, 1999, 37: 139-157.
24. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, Brandenburger GH and W.R. W. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation, 1998, 98: 1-5.
25. Weller GE, Lu E, Csikari MM, Klibanov AL, Fischer D, Wagner WR and Villanueva FS. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation, 2003, 108: 218-224.
26. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR and Villanueva FS. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res., 2005, 65: 533-539.
27. Hauff P, Reinhardt M, Briel A, Debus N and Schirner M. Molecular targeting of lymph nodes with Lselectin lignad-specific us contrast agent: a feasibility study in mice and dogs. Radiology, 2004, 231: 667-673.
28. Schumann PA, Christiansen JP, Quigley RM, McCreery TP, Sweitzer RH, Unger EC, Lindner JR and Matsunaga TO. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest. Radiol., 2002, 37: 587-593.
29. Weller GE, Villanueva FS, Tom EM and Wagner WR. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewis. Biotechnol. Bioeng., 2005, 92: 780-788.
30. Borden MA, Sarantos MR, Stieger SM, Simon SI, Ferrara KW and Dayton PA. Ultrasound radiation force modulates ligand availability on targeted contrast agents. Molecular Imaging, 2006, 5: 139-147.
31. Rapoport NY, Kennedy AM, Shea JE, Scaife CL and Nam K-H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Controlled Release, 2009, 138: 268-276.
32. Campbell R. Tumor physiology and delivery of nanopharmaceuticals. Ant Canc. Agents Med. Chem., 2006, 6(6): 503-512.
33. Reznik N, Williams R and Burns PN. Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent. Ultrasound in Medicine and Bilogy, 2011, 37(8): 1271-1279.
34. Zhang P and Porter T. An in vitro of a phase-shift nanoemulsion: A potential nucleation agent for bubble-enhanced HIFU tumor ablation. Ultrasound in Medicine & Biology, 2010, 36(11): 1856-1866.
35. Huang SL. Liposomes in ultrasonic drug and gene delivery. Advanced Drug Delivery Reviews, 2008, 60(10): 1167-1176.
36. Schroeder A, Kost J and Barenholz y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chemistry and Physics of Lipids, 2009, 162: 1-16.
37. Allen TM. Liposomes: opportunities in drug delivery. Drugs, 1997, 54: 8-14.
38. Ranson MR, Carmichael J, O'Byrne K, Stewart S, Smith D and Hwell A. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J. Clin. Oncol., 1997, 15: 3185-3191.
39. Gasselhuber A, Dreher MR, Partanen A, Yarmolenko PS, Woods D, Wood BJ and Haemmerich D. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: Computational modelling and preliminary in vivo validation. International Journal of Hyperthermia, 2012, 28(4): 337-348.
40. Chilkoti A, Dreher MR, Meyer DE and Raucher D. Targeted drug delivery by thermally responsive polymers. Advanced Drug Delivery Reviews, 2002, 54: 613-630.
41. Ferrara KW, M.A. B and Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Accounts of Chemical Research, 2009, 42(7): 881-892.
42. Huang SL and MacDonald RC. Acoustically active liposomes for drug encapsulation and ultrasoundtriggered release. Biochimica et Biophysica Acta, 2004, 1665: 134-141.
43. Kheirolomoom A, Dayton PA, Lum AFH, Little E, Paoli EE, Zheng HR and Ferrara KW. Acousticallyactive microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. Journal of Controlled Release, 2007, 118: 275-284.
44. Endo-Takahashi Y, Negishi Y, Kato Y, Suzuki R, Maruyama K and Aramaki Y. Efficient siRNA delivery using novel siRNA-loaded bubble liposomes and ultrasound. Int. J. Pharm., 2012, 422(1-2): 504-509.
45. Negishi Y, Endo-Takahashi Y, Matsuki Y, Kato Y, Takagi N, Suzuki R, Maruyama K and Aramaki Y. Systemic delivery systems of angiogenic gene by novel bubble liposomes containing cationic lipid and ultrasound exposure. Mol. Pharm., 2012, 9(6): 1834-1840.
46. Lum AFH, M.A. B, Dayton PA, Kruse DE, Simon SI and Ferrara KW. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J. Controlled Release, 2006, 111: 128-134.
47. Rapoport N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. International Journal of Pharmaceutics, 2004, 277: 155-162.
48. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Progress in Polymer Science, 2007, 32: 962-990.
49. Marin A, Sun H, Husseini GA, Pitt WG, Christensen DA and Rapoport NY. Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. Journal of Controlled Release, 2002, 84(1): 39-47.
50. Wan CPL, Jackson JK, Pirmoradi FN, Chiao M and Burt HM. Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-Glycoprotein-expressing cell lines following ultrasound exposure. Ultrasound in medicine & biology, 2012, 38(5): 736-744.
51. Rapoport N. Ultrasound-mediated micellar drug delivery. International Journal of Hyperthermia, 2012, 28(4): 374-385.
52. Dijkmans PA, Juffermans LJ, Musters RJ, van Wamel A, ten Cate FJ, van Gilst W, Visser CA, de Jong N and Kamp O. Microbubbles and ultrasound: from diagnosis to therapy. European Journal of Echocardiography, 2004, 5: 245-256.
53. ter Haar G. Therapeutic ultrasound. European Journal of Ultrasound, 1999, 9(1): 3-9.
54. Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K and Nishigaki R. Recent advances in sonodynamic approach to cancer therapy. Ultrasonics Sonochemistry, 1996, 3: S187-S191.
55. Ng KY and Liu Y. Therapeutic ultrasound: its application in drug delivery. Medicinal Research Reviews, 2002, 22(2): 204-223.
56. Rychak JJ, Klibanov AL, Ley KF and Hossack JA. Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound in Medicine & Biology, 2007, 33(7): 1132-1139.
57. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv. Drug Deliv. Rev., 2008, 60: 1193-1208.
58. Billard B, Hynynen K and Roemer R. Effects of physical parameters on high temperature ultrasound hyperthermia. Ultrasound in medicine & biology, 1990, 16(4): 409-420.
59. Partanen A, Yarmolenko PS, Viitala A, Appanaboyina S, Haemmerich D, Ranjan A, Jacobs G, Woods D, Enholm J and Wood BJ. Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery. International Journal of Hyperthermia, 2012, 28(4): 320-336.
60. Chomas JE, Dayton P, Allen J, Morgan K and Ferrara KW. Optical observation of contrast agent destruction. Appl. Phys. Lett., 2000, 77: 1056-1058.
61. Chomas JE, Dayton PA, May D, Allen J, Klibanov K and Ferrara KW. Optical observation of contrast agent destruction. Appl. Phys. Lett., 2000, 77: 1056-1058.
62. Marmottant P, Meer Svd, Emmer M, Versluis M, Jong Nd, Hilgenfeldt S and Lohse D. A model for large amplitude oscillations of coated bubbles accounting for buckling and rupture. J. Acous. Soc. Am., 2005, 118(6): 3499-3505.
63. Brennen CE. Cavitation and bubble dynamics, Oxford University Press, USA, 1995.
64. Sboros V. Response of contrast agents to ultrasound. Advanced Drug Delivery Reviews, 2008, 60(10): 1117-1136.
65. Ferrara KW. Driving delivery vehicles with ultrasound. Advanced Drug Delivery Reviews, 2008, 60: 1097-1102.
66. Kimmel E. Cavitation bioeffects. Critical reviews in biomedical engineering, 2006, 34(2): 105.
67. Miller MW, Miller DL and Brayman AA. Areview of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound in Medicine & Biology, 1996, 22(9): 1131-1154.
68. Morgan KE, Allen JE, Dayton PA, Chomas JE, Klibaov AL and Ferrara KW. Experimental and theoretical evaluaiton of microbubble behavior: effect of transmitted phase and bubble size. IEEE transactions on Ultrasonics, Ferroelectrics and Frequency Control, 2000, 47(6): 1494-1509.
69. Suslick KS. Sonochemistry. Science, 1990, 247(4949): 1439-1445.
70. Larina I, Evers B, Bartels C, Ashitkov T, Larin K and Esenaliev R. Ultrasound-enhanced drug delivery for efficient cancer therapy. 2002, 1:492-493 vol. 1.
71. Mehier-Humbert S, Bettinger T, Yan F and Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. Journal of Controlled Release, 2005, 104: 213-222.
72. Miller DL, Pislaru SV and Greenleaf JF. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somatic cell and molecular genetics, 2002, 27(1): 115-134.
73. Miller DL and Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound in medicine & biology, 2000, 26(4): 661-667.
74. Ohl CD, Arora M, Ikink R, De Jong N, Versluis M, Delius M and Lohse D. Sonoporation from jetting cavitation bubbles. Biophysical Journal, 2006, 91(11): 4285-4295.
75. Qiu Y, Luo Y, Zhang Y, Cui W, Zhang D, Wu J, Zhang J and Tu J. The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. Journal of Controlled Release, 2010, 145: 40-48.
76. Ward M, Wu J and Chiu JF. Experimental study of the effects of optison® concentration on sonoporation in vitro. Ultrasound in Medicine & Biology, 2000, 26(7): 1169-1175.
77. Kuroki M, Hachimine K, Abe H, Shibaguchi H, Maekawa SI, Yanagisawa J, Kinugasa T, Tanaka T and Yamashita Y. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Research, 2007, 27(6A): 3673-3677.
78. Yumita N, Nishigaki R, Umemura K, Morse PD, Swartz HM, Cain CA and Umemura S. Sonochemical activation of Hematoporphyrin: an ESR study. Radiation Res., 1994, 138: 171-176.
79. Larina IV, Evers BM, Ashitkov TV, Bartels C, VLarin KV and Esenaliev RO. Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation. Technology in Cancer Research & Treatment, 2005, 4(2): 217-226.
80. Larina IV, Evers BM and Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasoundinduced cavitation. Anticancer Research, 2005, 25: 149-156.
81. Kopechek JA, Park E, Mei C-S, McDannold NJ and Porter TM. Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo. Journal of Healthcare Engineering, 2013, 4(1): 109-126.
82. Tartis MS, Kruse DE, Zheng HR, Zhang H, Kheirolomoom A, Marik J and Ferrara KW. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J. Controlled Release, 2008, 131: 160-166.
83. Dromi S, Frenkel V, Luk A, Traughber B, Angstadt M, Bur M, Poff J, Xie JW, Libutti SK, Li KCP and Wood BJ. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin. Cancer Res., 2007, 13(9): 2722-2727.
84. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y and Fukushima S. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control Release, 2000, 64: 143-153.
85. Husseini GA, Myrup G, Pitt WG, Christensen DA and Rapoport N. Factors affecting acoustically triggered release of drugs from polymeric micelles. J. Controlled Release, 2000, 69: 43-52.
86. Rapoport N, Marin A, Luo Y, Prestwich G and Muniruzzaman M. Intracellular uptake and trafficking of pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization. J. Pharm. Sci., 2002, 91: 157-170.
87. Munshi N, Rapoport N and Pitt WG. Ultrasonic activated drug delivery from Pluronic P-105 micelles. Cancer Letters, 1997, 118: 13-19.
88. Greenleaf WJ, Bolander ME, Sarkar G, Goldring MB and Greenleaf JF. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound in Medicine & Biology, 1998, 24: 587-595.
89. Uchida T, Tachibana K, Hisano S and Morioka E. Elimination of adult T cell leukemia cells by ultrasound in the presence of porfimer sodium. Anti-cancer Drugs, 1997, 8(4): 329-335.
90. Xing Z, Wang J, Ke H, Zhao B, Yue X, Dai Z and Liu J. The fabricaiton of novel nanobubble ultrasound contrast agent for potential tumor imaging. Nanotechnology, 2010, 21: 145607.
91. Cavalli R, Bisazza A, Trotta M, Argenziano M, Civra A, Donalisio M and Lembo D. New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization. Int. J. Nanomedicine, 2012, 7: 3309-3318.
92. Lapotko D. Plasmonic nanobubbles as tunable cellular probes for cancer theranostics. Cancers, 2011, 3(1): 802-840.
93. Perez JLJ, Orea AC, Gallegos ER and Fuentes RG. Photoacoustic spectroscopy to determine in vitro the nonradiative relaxation time of porotoporphyrin IX solution containing gold metallic nanoparticles. Eur. Phys. J. Spec. Top, 2008, 152: 353-356.
94. Yamaguchi S, Kobayashi H, Narita T, Kanehira K, Sonezaki S, Kudo N, Kubota Y, Terasaka S and Houkin K. Sonodynamic therapy using water-dispersed TiO2-polyethylene glycol compound on glioma cells: comparison of cytotoxic mechanism with photodynamic therapy. Ultrason. Sonochem., 2011, 18: 1197-1204.
95. Petty HR. Spatiotemporal chemical dynamics in living cells: From inforamtion trafficking to cell physiology. Biosystems, 2006, 83: 217-224.
96. Park J, Fan Z, Kumon RE, El-Sayed MEH and Deng CX. Modulation of intracellular CA2+ concentration in brain microvascular endothelial cells in vitro by acoustic cavitation. Ultrasound in Medicine & Biology, 2010, 36(7): 1176-1187.
97. Zhong W, Sit WH, Wan JMF and Yu ACH. Sonoporation induces apoptosis and cell cycle arrest in human promyelocytic leukemia cells. Ultrasound in Medicine & Biology, 2011, 37(12): 2149-2159.
98. Guzman HR, Nguyen DX, McNamara AJ and Prausnitz MR. Equilibrium loading of cells with macromolecules by ultrasound: effects of molecular size and acoustic energy. J. Pharm. Sci., 2002, 91: 1693-1701.
99. Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A and Akbar M. Strategy for effective brain drug delivery. European Journal of Pharmaceutical Sciences, 2010, 40(5): 385-403.
100. Hynynen K, McDannold N, Vykhodtseva N and Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology, 2001, 220: 640-646.
101. McDannold N, Vykhodtseva N and Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound in medicine & biology, 2008, 34(6): 930-937.
102. O'Reilly MA and Hynynen K. Ultrasound enhanced drug delivery to the brain and central nervous system. International Journal of Hyperthermia, 2012, 28(4): 386-396.
103. Chen P-Y, Liu H-L, Hua M-Y, Yang H-W, Huang C-Y, Chu P-C, Lvu L-A, Tseng I-C, Feng L-Y, Tsai H-C, Chen S-M, Lu Y-J, Wang J-J, Yen T-C, Ma Y-H, Wu T, Chen J-P, Chuang J-I, Shin J-W, Hsueh C and Wei K-C. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro. Oncol., 2010, 12(10): 1050-1060.
104. Liu H-L, Hua M-Y, Chen P-Y, Chu P-C, Pan C-H, Yang H-W, Huang C-Y, Wang J-J, Yen T-C and Wei K-C. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology, 2010, 255: 415-425.
105. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res., 2000, 33: 94-101.
106. Polat BE, Hart D, Langer R and Blankschtein D. Ultrasound-mediated transdermal drug delivery: Mechanism, scope, and emerging trends. Journal of Controlled Release, 2011, 152(3): 330-348.